Case Report: Severe Rashes Associated With Fruquintinib in a Patient With Metastatic Colorectal Cancer

Shu, YF; Zheng, S

Shu, YF; Zheng, S (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Canc Hosp, Dept Med Oncol, Hangzhou, Peoples R China.; Zheng, S (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Peoples Hosp 1, Dept Med Oncol, Hangzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2021; 11 ():

Abstract

Metastatic colorectal cancer (mCRC) is a common and high-risk malignant tumor. Fruquintinib is a novel small-molecule compound with high selective inh......

Full Text Link